πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Theravance Biopharma Ireland Patents

Full USPTO pharma patent portfolio for Theravance Biopharma Ireland β€” grant dates, expiration, and drug cross-links.

Patents
635
Expiring ≀24m
58

Quick answer

Theravance Biopharma Ireland has 635 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 58 expire within 24 months β€” use filters for patent-cliff planning.

Page 11 of 14

  1. US 7615566

    Substituted pyrrolidine and related compounds

    Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7612037

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7604944

    Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

    Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7601690

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7592355

    Quinolinone-carboxamide compounds as 5-HT, receptor agonists

    Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7585879

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7585653

    Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

    Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7582765

    Aryl aniline Ξ²2 adrenergic receptor agonists

    Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7572918

    Process for preparing substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds

    Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7569586

    Compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7569588

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7566785

    Amidine substituted aryl aniline compounds

    Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7560469

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7557126

    Diphenylmethyl compounds useful as muscarinic receptor antagonists

    Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7557247

    Crystalline form of Ξ²2 adrenergic receptor agonist

    Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7553962

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7553971

    Aryl aniline Ξ²2 adrenergic receptor agonists

    Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7550595

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7544364

    Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin

    Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7534889

    5-HT4 receptor agonist compounds

    Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7531623

    Hydrochloride salts of a glycopeptide phosphonate derivative

    Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7528253

    Compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7524959

    Biphenyl derivatives

    Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7524880

    Crystalline form of a substituted pyrrolidine compound

    Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7524965

    Dialkylphenyl compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7524962

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7521558

    Crystalline form of a biphenyl compound

    Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7521561

    Biphenyl derivatives

    Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7521418

    Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent

    Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7521041

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7514425

    Short-acting sedative hypnotic agents for anesthesia and sedation

    Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7514558

    Biphenyl derivatives

    Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7507751

    Biphenyl derivatives

    Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7501442

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7498442

    Quinolinone-carboxamide compounds

    Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7491736

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7479562

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7468420

    Process for purifying glycopeptide phosphonate derivatives

    Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7456203

    Muscarinic receptor antagonists

    Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7456199

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7452995

    Aryl aniline Ξ²2 adrenergic receptor agonists

    Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7452861

    Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent

    Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7446114

    Quinolinone compounds as 5-HT4 receptor agonists

    Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7427639

    Ξ²2-adrenergic receptor agonists

    Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7419989

    Indazole-carboxamide compounds

    Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7405199

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7402673

    Diamine Ξ²2 adrenergic receptor agonists

    Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7399863

    Amino-substituted ethylamino Ξ²2 adrenergic receptor agonists

    Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Theravance Biopharma Ireland have?

635 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Theravance Biopharma Ireland patents expire?

58 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.